MHRA Warning: Pancreatitis Risk with Ozempic, Wegovy, Mounjaro
Medical regulators urge vigilance for rare but severe pancreatitis symptoms in patients using popular GLP-1 medications like Ozempic, Wegovy and Mounjaro across the UK.
Category : Pharmaceuticals
Eli Lilly's $3.5bn Pennsylvania Plant for Drug Production
Pharmaceutical giant Eli Lilly announces a major $3.5 billion manufacturing facility in Pennsylvania, expanding domestic production to meet soaring demand for its obesity and diabetes treatments.
NHS Amitriptyline Warning: Nine Groups Must Consult Doctors
The NHS advises nine specific groups to consult doctors before taking amitriptyline for pain relief, depression, or migraines. Key warnings include heart conditions, pregnancy, and medication interactions.
Peanut Allergy Drug Palforzia Pulled from Shelves
The only licensed immunotherapy for peanut allergy in young people is being discontinued globally, described as a commercial decision that leaves families without treatment options.
GLP-1 Drugs Linked to Pancreatitis Risk, MHRA Warns
The MHRA has updated safety information for Wegovy, Ozempic and Mounjaro to highlight a small but serious risk of severe acute pancreatitis, following a UK death linked to the medication.
AstraZeneca's £13.4bn Chinese Weight Loss Drug Deal
AstraZeneca announces a major £13.4 billion partnership with China's CSPC to develop monthly weight loss injections, aiming to challenge market leaders like Ozempic.
Trump: Eli Lilly Building Six New US Pharmaceutical Plants
Former President Donald Trump reveals pharmaceutical giant Eli Lilly plans to construct six new manufacturing facilities across the United States, expanding on previous investment announcements.
AstraZeneca's £11bn China Investment After UK Row
Britain's largest pharmaceutical firm AstraZeneca reveals a major $15bn investment in China during Keir Starmer's visit, months after scaling back UK expansion plans amid government disputes.
UK Seizes £4m in Illegal Dermal Fillers
The MHRA has confiscated over 27,000 units of unlicensed dermal fillers since 2020, valued at up to £4 million, with a sharp rise in seizures in 2023.
MHRA Seizes £4m in Illegal Dermal Fillers
The Medicines and Healthcare products Regulatory Agency has confiscated over 27,000 unlicensed dermal filler units since 2020, warning they pose serious health risks including disfigurement and infection.
AstraZeneca Pledges $15bn China Investment on Starmer Trip
British pharmaceutical giant AstraZeneca has announced a major $15 billion investment in China by 2030, the largest deal of Prime Minister Keir Starmer's diplomatic visit to Beijing.
Weight Loss Jab Lawsuits Surge Over Side Effects
Thousands of patients have filed lawsuits against pharmaceutical companies, alleging severe side effects from popular weight-loss injections like Ozempic and Wegovy.
Weight-Loss Drug Lawsuits Surge Over Side Effects
Thousands of patients are suing pharmaceutical giants over severe side effects from GLP-1 weight-loss drugs, including eye strokes and ruptured colons, despite company assurances of rigorous testing.
Trump Administration Targets 15 Drugs for Medicare Price Talks
The Trump administration has selected 15 new medications, including treatments for diabetes, HIV, and arthritis, for Medicare price negotiations under a 2022 law, aiming to reduce costs for seniors and taxpayers.
Bunnie Xo Reveals Terrifying Weight Loss Drug Side Effects
Jelly Roll's wife Bunnie Xo details terrifying depression from unapproved weight loss drug retatrutide, warning others about online claims and fake medicines.
Pressure Mounts on Ministers Over Secret US Drug Deal
MPs demand transparency on the UK-US zero tariff drug agreement, with critics warning of hidden costs to the NHS and economy by 2035.
UK Sees Surge in Fake Weight Loss Jabs, MHRA Warns
New MHRA data reveals over 6,500 counterfeit weight loss injections seized in the UK since 2023, highlighting a dangerous black market rise with serious health risks.
Fake Weight Loss Jab Seizures Soar in UK
Over 6,500 counterfeit weight loss injections seized in three years as black market grows, raising serious patient safety concerns across Britain.
Trump Policy Drives Record Obesity Drug Costs in Scotland
Scotland's NHS spending on weight-loss injections hits nearly £3 million monthly, with costs soaring after US price hikes linked to Donald Trump's policies.
Weight-Loss Jab Myths Exposed by Leading Pharmacist
A leading dieting pharmacist clarifies facts versus fiction about home weight-loss treatments, highlighting dangerous assumptions and revealing surprising side effects like hair loss and sulphur burps.
Fake Weight-Loss Pills Threaten UK as Oral Treatments Near
Experts warn that counterfeit weight-loss tablets could flood Britain, urging stronger regulation before oral versions of drugs like Wegovy are approved, as pills are easier to fake than injections.
Baby turns blue after drinking recalled formula
A mother recounts rushing her three-month-old to hospital with blue feet and grunting after feeding him Nestlé SMA formula, later linked to a recall over cereulide toxin fears.
UK Aspirin Shortage Leads to Export Ban and Supply Issues
Britain confronts a severe aspirin shortage, with 86% of pharmacies unable to supply the drug, leading to rationing and price hikes as the government imposes an export ban to protect stocks.
Guinea-Bissau Suspends US Vaccine Study Over Ethics
Guinea-Bissau suspends a US-funded hepatitis B vaccine trial, citing ethical concerns and national sovereignty, as US officials dispute the decision.
Critical Aspirin Shortages Hit UK Pharmacies
Pharmacies across Britain report severe aspirin shortages, with 86% unable to supply patients. The National Pharmacy Association warns of dangerous implications for heart and stroke patients.
UK Aspirin Shortage: Export Ban Imposed
Britain confronts widespread aspirin shortages, prompting government export restrictions. Pharmacists ration stock as prices soar, impacting heart and stroke patients.
Mother's Life-Threatening Reaction to Counterfeit Weight Loss Drug
A Brazilian mother-of-one is fighting for her life after using an illegal weight loss drug, suffering seizures and requiring emergency tracheostomy surgery. The case highlights dangers of unregulated medications.
Deadly Illness from Illegal Weight Loss Drug
A 42-year-old Brazilian woman has been diagnosed with rare Guillain-Barré Syndrome after using an unregulated weight loss pen from Paraguay, highlighting the dangers of unlicensed medications.
Tirzepatide Surpasses Ozempic in US Weight Loss Market
New data reveals tirzepatide has overtaken semaglutide as the most prescribed weight loss medication in the US, with prescriptions surging 10% while Ozempic prescriptions decline.
Doctors Push FDA to Ban Benadryl Over Brain Damage Risks
Medical experts call for removal of diphenhydramine from US shelves, citing severe side effects including dementia risk, impaired driving, and thousands of hospitalisations annually.
Page 1 of 16